Work

A Refined Clinical Risk Score at Onset of Treatment for Acute Gvhd That Predicts Response to Initial Therapy, Survival and Transplant-Related Mortality

Year: 2014

Type: article

Source: Blood

DOI: 10.1182/blood.v124.21.188.188

Authors: Margaret L. MacMillan, Marie Robin, Andrew C Harris, Todd E. Defor, Paul J. Martin, Amin Alousi, Vincent T Ho, Javier Bolanos-Meade, James L.M. Ferrara, Richard J. Jones, Mukta Arora, Bruce R. Blazar, Shernan G. Holtan, David Jacobsohn, Marcelo C. Pasquini, Gerard Socie, Joseph H. Antin, John E. Levine, Daniel J. Weisdorf

Institutions: University of Minnesota, Hôpital Saint-Louis, University of Michigan, Fred Hutch Cancer Center, The University of Texas MD Anderson Cancer Center, Harvard University, Dana-Farber Cancer Institute, Johns Hopkins University, Children's National, Medical College of Wisconsin

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2979381668

FWCI:

Cites:

Cited by:

Related to: 10